Vdac2 has been shown to decrease with age and with increased pathology in 3xTg‐AD, suggesting that Ch‐ may downregulate this protein, contributing to mitochondrial dysfunction (Singulani et al., 2020). This evidence concerns the gene VDAC2 and Alzheimer disease.